News and

Curesponse Presents Positive Preliminary Clinical Results from a Multi-Center UK Study at AACR

Curesponse discusses its cancer prediction cResponse™ test with Ynet (in hebrew)

Yahoo finance logo - Curesponse announces coverage for cResponse Test with Clalit Health Services

Curesponse Announces Clalit Health Services, Largest Israeli HMO, to Provide Commercial Coverage for the cResponse™ test

Curesponse shows applicability with next generation immuno-oncology drugs

Curesponse to exhibit at ASCO, 2022

Curesponse to present at BIOMED Israel, 2022

Curesponse publishes new clinical study in Nature Cancer


Curesponse and Rafael announce collaboration

Channel 13

Curesponse interviewed on Israel Channel 13


Curesponse secures additional USD 8 Million funding

Want to know more?

Contact Us